92 related articles for article (PubMed ID: 10646722)
1. Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas.
Shibosawa E; Tsutsumi K; Koizuka I; Hoshikawa M; Takakuwa T
Laryngoscope; 2000 Jan; 110(1):93-7. PubMed ID: 10646722
[TBL] [Abstract][Full Text] [Related]
2. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
3. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
Mäkitie AA; MacMillan C; Ho J; Shi W; Lee A; O'Sullivan B; Payne D; Pintilie M; Cummings B; Waldron J; Warde P; Irish J; Brown D; Gilbert R; Gullane P; Liu FF; Kamel-Reid S
Clin Cancer Res; 2003 Jun; 9(6):2177-84. PubMed ID: 12796384
[TBL] [Abstract][Full Text] [Related]
4. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
6. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
[TBL] [Abstract][Full Text] [Related]
7. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
8. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
9. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
[TBL] [Abstract][Full Text] [Related]
10. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
11. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
[TBL] [Abstract][Full Text] [Related]
12. [EB virus infection and expression of P53 and P16 in non-Hodgkin's lymphoma].
Wu L; Gu G; Ma D
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 34(6):359-61. PubMed ID: 12764846
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
16. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization.
Chen PC; Pan CC; Yang AH; Wang LS; Chiang H
J Pathol; 2002 Aug; 197(5):684-8. PubMed ID: 12210090
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients.
Karim N; Pallesen G
Malays J Pathol; 2003 Jun; 25(1):45-7. PubMed ID: 16196377
[TBL] [Abstract][Full Text] [Related]
18. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx.
Hwang TZ; Jin YT; Tsai ST
Anticancer Res; 1998; 18(6B):4581-4. PubMed ID: 9891522
[TBL] [Abstract][Full Text] [Related]
19. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between Fas/Fas-ligand expression and apoptosis in undifferentiated nasopharyngeal carcinoma].
Enami A; Tsutsumi K; Kobayashi T; Shibosawa E; Koizuka I
Nihon Jibiinkoka Gakkai Kaiho; 2002 Oct; 105(10):1087-92. PubMed ID: 12440162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
